Global Valsartan Drug Sales Market Report 2021

1 Valsartan Drug Market Overview

• 1.1 Valsartan Drug Product Scope
• 1.2 Valsartan Drug Segment by Type
  • 1.2.1 Global Valsartan Drug Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 40 mg Tablets
  • 1.2.3 80 mg Tablets
  • 1.2.4 160 mg Tablets
  • 1.2.5 320 mg Tablets
• 1.3 Valsartan Drug Segment by Application
  • 1.3.1 Global Valsartan Drug Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hypertension
  • 1.3.3 Heart Failure
  • 1.3.4 Heart Attack
• 1.4 Valsartan Drug Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Valsartan Drug Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Valsartan Drug Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Valsartan Drug Price Trends (2016-2027)

2 Valsartan Drug Estimates and Forecasts by Region

• 2.1 Global Valsartan Drug Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Valsartan Drug Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Valsartan Drug Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Valsartan Drug Revenue Market Share by Region (2016-2021)
• 2.3 Global Valsartan Drug Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Valsartan Drug Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Valsartan Drug Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Valsartan Drug Estimates and Projections (2016-2027)
  • 2.4.2 Europe Valsartan Drug Estimates and Projections (2016-2027)
  • 2.4.3 China Valsartan Drug Estimates and Projections (2016-2027)
  • 2.4.4 Japan Valsartan Drug Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Valsartan Drug Estimates and Projections (2016-2027)
  • 2.4.6 India Valsartan Drug Estimates and Projections (2016-2027)

3 Global Valsartan Drug Competition Landscape by Players

• 3.1 Global Top Valsartan Drug Players by Sales (2016-2021)
• 3.2 Global Top Valsartan Drug Players by Revenue (2016-2021)
• 3.3 Global Valsartan Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Valsartan Drug as of 2020)
• 3.4 Global Valsartan Drug Average Price by Company (2016-2021)
• 3.5 Manufacturers Valsartan Drug Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Valsartan Drug Market Size by Type

• 4.1 Global Valsartan Drug Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Valsartan Drug Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Valsartan Drug Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Valsartan Drug Price by Type (2016-2021)
• 4.2 Global Valsartan Drug Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Valsartan Drug Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Valsartan Drug Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Valsartan Drug Price Forecast by Type (2022-2027)

5 Global Valsartan Drug Market Size by Application

• 5.1 Global Valsartan Drug Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Valsartan Drug Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Valsartan Drug Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Valsartan Drug Price by Application (2016-2021)
• 5.2 Global Valsartan Drug Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Valsartan Drug Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Valsartan Drug Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Valsartan Drug Price Forecast by Application (2022-2027)

6 North America Valsartan Drug Market Facts & Figures

• 6.1 North America Valsartan Drug Sales by Company
  • 6.1.1 North America Valsartan Drug Sales by Company (2016-2021)
  • 6.1.2 North America Valsartan Drug Revenue by Company (2016-2021)
• 6.2 North America Valsartan Drug Sales Breakdown by Type
  • 6.2.1 North America Valsartan Drug Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Valsartan Drug Sales Breakdown by Type (2022-2027)
• 6.3 North America Valsartan Drug Sales Breakdown by Application
  • 6.3.1 North America Valsartan Drug Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Valsartan Drug Sales Breakdown by Application (2022-2027)

7 Europe Valsartan Drug Market Facts & Figures

• 7.1 Europe Valsartan Drug Sales by Company
  • 7.1.1 Europe Valsartan Drug Sales by Company (2016-2021)
  • 7.1.2 Europe Valsartan Drug Revenue by Company (2016-2021)
• 7.2 Europe Valsartan Drug Sales Breakdown by Type
  • 7.2.1 Europe Valsartan Drug Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Valsartan Drug Sales Breakdown by Type (2022-2027)
• 7.3 Europe Valsartan Drug Sales Breakdown by Application
  • 7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)

8 China Valsartan Drug Market Facts & Figures

• 8.1 China Valsartan Drug Sales by Company
  • 8.1.1 China Valsartan Drug Sales by Company (2016-2021)
  • 8.1.2 China Valsartan Drug Revenue by Company (2016-2021)
• 8.2 China Valsartan Drug Sales Breakdown by Type
  • 8.2.1 China Valsartan Drug Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Valsartan Drug Sales Breakdown by Type (2022-2027)
• 8.3 China Valsartan Drug Sales Breakdown by Application
  • 8.3.1 China 163 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 163 Sales Breakdown by Application (2022-2027)

9 Japan Valsartan Drug Market Facts & Figures

• 9.1 Japan Valsartan Drug Sales by Company
  • 9.1.1 Japan Valsartan Drug Sales by Company (2016-2021)
  • 9.1.2 Japan Valsartan Drug Revenue by Company (2016-2021)
• 9.2 Japan Valsartan Drug Sales Breakdown by Type
  • 9.2.1 Japan Valsartan Drug Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Valsartan Drug Sales Breakdown by Type (2022-2027)
• 9.3 Japan Valsartan Drug Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Valsartan Drug Market Facts & Figures

• 10.1 Southeast Asia Valsartan Drug Sales by Company
  • 10.1.1 Southeast Asia Valsartan Drug Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Valsartan Drug Revenue by Company (2016-2021)
• 10.2 Southeast Asia Valsartan Drug Sales Breakdown by Type
  • 10.2.1 Southeast Asia Valsartan Drug Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Valsartan Drug Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Valsartan Drug Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Valsartan Drug Market Facts & Figures

• 11.1 India Valsartan Drug Sales by Company
  • 11.1.1 India Valsartan Drug Sales by Company (2016-2021)
  • 11.1.2 India Valsartan Drug Revenue by Company (2016-2021)
• 11.2 India Valsartan Drug Sales Breakdown by Type
  • 11.2.1 India Valsartan Drug Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Valsartan Drug Sales Breakdown by Type (2022-2027)
• 11.3 India Valsartan Drug Sales Breakdown by Application
  • 11.3.1 India Valsartan Drug Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Valsartan Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Valsartan Drug Business

• 12.1 Novartis
  • 12.1.1 Novartis Corporation Information
  • 12.1.2 Novartis Business Overview
  • 12.1.3 Novartis Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Novartis Valsartan Drug Products Offered
  • 12.1.5 Novartis Recent Development
• 12.2 Sun Pharmaceutical
  • 12.2.1 Sun Pharmaceutical Corporation Information
  • 12.2.2 Sun Pharmaceutical Business Overview
  • 12.2.3 Sun Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Sun Pharmaceutical Valsartan Drug Products Offered
  • 12.2.5 Sun Pharmaceutical Recent Development
• 12.3 Teva
  • 12.3.1 Teva Corporation Information
  • 12.3.2 Teva Business Overview
  • 12.3.3 Teva Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Teva Valsartan Drug Products Offered
  • 12.3.5 Teva Recent Development
• 12.4 Mylan
  • 12.4.1 Mylan Corporation Information
  • 12.4.2 Mylan Business Overview
  • 12.4.3 Mylan Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Mylan Valsartan Drug Products Offered
  • 12.4.5 Mylan Recent Development
• 12.5 Alembic Pharmaceuticals
  • 12.5.1 Alembic Pharmaceuticals Corporation Information
  • 12.5.2 Alembic Pharmaceuticals Business Overview
  • 12.5.3 Alembic Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Alembic Pharmaceuticals Valsartan Drug Products Offered
  • 12.5.5 Alembic Pharmaceuticals Recent Development
• 12.6 Lupin
  • 12.6.1 Lupin Corporation Information
  • 12.6.2 Lupin Business Overview
  • 12.6.3 Lupin Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Lupin Valsartan Drug Products Offered
  • 12.6.5 Lupin Recent Development
• 12.7 Aurobindo Pharma
  • 12.7.1 Aurobindo Pharma Corporation Information
  • 12.7.2 Aurobindo Pharma Business Overview
  • 12.7.3 Aurobindo Pharma Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Aurobindo Pharma Valsartan Drug Products Offered
  • 12.7.5 Aurobindo Pharma Recent Development
• 12.8 Macleods Pharmaceuticals
  • 12.8.1 Macleods Pharmaceuticals Corporation Information
  • 12.8.2 Macleods Pharmaceuticals Business Overview
  • 12.8.3 Macleods Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Macleods Pharmaceuticals Valsartan Drug Products Offered
  • 12.8.5 Macleods Pharmaceuticals Recent Development
• 12.9 HETERO
  • 12.9.1 HETERO Corporation Information
  • 12.9.2 HETERO Business Overview
  • 12.9.3 HETERO Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 HETERO Valsartan Drug Products Offered
  • 12.9.5 HETERO Recent Development
• 12.10 Torrent Pharmaceuticals
  • 12.10.1 Torrent Pharmaceuticals Corporation Information
  • 12.10.2 Torrent Pharmaceuticals Business Overview
  • 12.10.3 Torrent Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Torrent Pharmaceuticals Valsartan Drug Products Offered
  • 12.10.5 Torrent Pharmaceuticals Recent Development
• 12.11 Huaren Pharmaceutical
  • 12.11.1 Huaren Pharmaceutical Corporation Information
  • 12.11.2 Huaren Pharmaceutical Business Overview
  • 12.11.3 Huaren Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Huaren Pharmaceutical Valsartan Drug Products Offered
  • 12.11.5 Huaren Pharmaceutical Recent Development
• 12.12 Jubilant Pharma
  • 12.12.1 Jubilant Pharma Corporation Information
  • 12.12.2 Jubilant Pharma Business Overview
  • 12.12.3 Jubilant Pharma Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Jubilant Pharma Valsartan Drug Products Offered
  • 12.12.5 Jubilant Pharma Recent Development
• 12.13 Amneal Pharmaceuticals
  • 12.13.1 Amneal Pharmaceuticals Corporation Information
  • 12.13.2 Amneal Pharmaceuticals Business Overview
  • 12.13.3 Amneal Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Amneal Pharmaceuticals Valsartan Drug Products Offered
  • 12.13.5 Amneal Pharmaceuticals Recent Development
• 12.14 Zhejiang Huahai Pharmaceutical
  • 12.14.1 Zhejiang Huahai Pharmaceutical Corporation Information
  • 12.14.2 Zhejiang Huahai Pharmaceutical Business Overview
  • 12.14.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Products Offered
  • 12.14.5 Zhejiang Huahai Pharmaceutical Recent Development
• 12.15 Square Pharmaceuticals
  • 12.15.1 Square Pharmaceuticals Corporation Information
  • 12.15.2 Square Pharmaceuticals Business Overview
  • 12.15.3 Square Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Square Pharmaceuticals Valsartan Drug Products Offered
  • 12.15.5 Square Pharmaceuticals Recent Development
• 12.16 Unichem Laboratories
  • 12.16.1 Unichem Laboratories Corporation Information
  • 12.16.2 Unichem Laboratories Business Overview
  • 12.16.3 Unichem Laboratories Valsartan Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Unichem Laboratories Valsartan Drug Products Offered
  • 12.16.5 Unichem Laboratories Recent Development

13 Valsartan Drug Manufacturing Cost Analysis

• 13.1 Valsartan Drug Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Valsartan Drug
• 13.4 Valsartan Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Valsartan Drug Distributors List
• 14.3 Valsartan Drug Customers

15 Market Dynamics

• 15.1 Valsartan Drug Market Trends
• 15.2 Valsartan Drug Drivers
• 15.3 Valsartan Drug Market Challenges
• 15.4 Valsartan Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List